Heart Failure

The AJMC® Heart Failure compendium is a comprehensive resource for clinical news and expert insights for the chronic condition in which the heart doesn't pump enough blood due to damaged heart muscle.

Latest News

The approval was based on results from the phase 3 FINEARTS-HF trial. | Image Credit: aznan - stock.adobe.com
FDA Approves Finerenone for Heart Failure With Mildly Reduced or Preserved LVEF

July 14th 2025

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events, based on FINEARTS-HF trial results.

Dallas Texas | Image Credit: © SeanPavonePhoto - stock.adobe.com
Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most

March 13th 2025

Phoenix Arizona | Image Credit: © Kevin Ruck - stock.adobe.com
Closing the Gaps in Cardiac Care With Technology, Collaboration

March 12th 2025

the top 5 heart failure content of 2024
Top 5 Most-Read Heart Failure Articles of 2024

December 23rd 2024

Top 5 conference coverage of 2024
Top 5 Conference Coverage of 2024

December 17th 2024

Continuing Medical Education
View All
July 16th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 16th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology
July 16th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
July 16th 2025

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology
July 16th 2025

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

1.5 Credits / Cardiology, Rare Diseases
July 16th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

Site Logo
December 6th 2022

On the Impact of Predictive Analytics–Driven Disease Management Interventions

Benjamin Ukert, PhD Guy David, PhD Aaron Smith-McLallen, PhD
Predictive analytics–driven disease management outperforms standard of care among patients with chronic heart failure.
Graphical representation of the heart
December 4th 2022

Dietary Energy Intake Potentially Linked to Heart Failure–Related Outcomes

Maggie L. Shaw
All-cause mortality was investigated among individuals who had heart failure as it related to their daily caloric intake and energy outcome.
Clinician examining cardiac function results
November 29th 2022

Potential for ICI-Related Arrhythmias Necessitates Recognizing Risk Early

Maggie L. Shaw
Researchers pulled data from the FDA’s Adverse Event Reporting System to analyze cardiac arrhythmia–related outcomes among patients on a mono or combination regimen for cancer treatment that included immune checkpoint inhibitors (ICIs).
Image of a heart monitor
November 24th 2022

Arrhythmia History Linked to Adverse Pregnancy Outcomes

Maggie L. Shaw
Study authors initiated this study because of a lack of data on arrhythmia trends among pregnant women who have been hospitalized for delivery, accounting for their age, comorbidities, and obesity status.
Tochi M. Okwuosa, DO, Rush University Medical Center
November 19th 2022

Dr Tochi Okwuosa: There Is a Great Need for Better CVD Risk Prediction in Cardio-Oncology

Maggie L. Shaw
In an interview at this year’s American Heart Association Scientific Sessions meeting in Chicago, Tochi M. Okwuosa, DO, cardiologist and director of cardio-oncology at Rush University Medical Center, discussed the importance of addressing cardiovascular disease (CVD) prevention in patients with cancer who are undergoing treatment.
Image of ECG
November 15th 2022

Sacubitril/Valsartan Linked to Improved Cardiac Autonomic Nervous System in HFrEF

Maggie L. Shaw
This international study, from investigators in Germany and Austria, looked at the effect sacubitril/valsartan can have among patients who have heart failure with reduced ejection fraction (HFrEF) and the impact on their cardiac autonomic nervous system.
Amresh Raina, MD, Allegheny Health Network
November 12th 2022

Dr Amresh Raina Addresses Gender Differences in HF Presentation

Maggie L. Shaw
Disease symptomatology may be the same, but the presentation of heart failure (HF) and heart attacks differ between women and men, explained Amresh Raina, MD, of the Allegheny Health Network in Pittsburgh, Pennsylvania.
Image of IV line
November 10th 2022

Comorbid Septic Shock, HFrEF Linked to Lack of Guideline-Recommended Treatment

Maggie L. Shaw
Patients with heart failure frequently suffer from fluid overload, and for those with heart failure with reduced ejection fraction (HFrEF) also suffering from septic shock—a condition often treated with fluids—more data are needed on outcomes following fluid administration.
Amresh Raina, MD, Allegheny Health Network
November 1st 2022

Dr Amresh Raina Illuminates Top Concerns in Asymptomatic Heart Failure

Maggie L. Shaw
Risk factors not properly addressed in patients with asymptomatic heart failure, such as high blood pressure and having diabetes or mild heart valve problems, can lead to structural heart problems or heart failure itself, noted Amresh Raina, MD, of the Allegheny Health Network in Pittsburgh, Pennsylvania.
Graphic of the words "heart failure"
October 26th 2022

Increasing HF-Related Mortality Concerning Among Young Adults, Experts Say

Maggie L. Shaw
The limited data on heart failure (HF)-related mortality among young adults, those aged 15 to 44 years, prompted this analysis of data from 1999 to 2019 that considered HF as a contributing or underlying cause of death.
Image of a patient standing out
October 21st 2022

Black Patients’ Uptake of Advanced HF Treatments Falls Behind That of White Patients

Maggie L. Shaw
Despite known racial disparities in access to advanced heart failure (HF) treatments, the reasons for this continue to require further exploration. In this new study, investigators searched for associations between ventricular assist device use and heart transplant and race (Black or White).
Amresh Raina, MD, Allegheny Health Network
October 19th 2022

Dr Amresh Raina Explains Radiation’s Impact on the Heart

Maggie L. Shaw
There is potential impact on the heart, coronary arteries, and heart function following radiation to the left side of the body, explained Amresh Raina, MD, director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania.
Image of a sick kid in the hospital
October 10th 2022

Heart Transplants Delayed During COVID-19 Pandemic for Pediatric Patients

Maggie L. Shaw
The impact of the COVID-19 pandemic on pediatric heart transplant waiting list times was evaluated in this new study that used data from the United Network for Organ Sharing.
Image of women vs men
October 5th 2022

Treatment Disparities Persist for Women vs Men Following MI

Maggie L. Shaw
Outcomes following a heart attack, or myocardial infarction (MI), were assessed among a large patient population in Ontario, Canada.
Amresh Raina, MD, Allegheny Health Network
October 3rd 2022

Dr Amresh Raina: Cancer Treatments Are Affecting Heart Function in Many Ways

Maggie L. Shaw
Amresh Raina, MD, director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania, is a board-certified advanced heart failure cardiologist, who is also certified in echocardiography and general cardiology.
Image of a person gently holding a heart
September 29th 2022

Worsened HF Outcomes Linked to Circulating Endotrophin Levels

Maggie L. Shaw
This potential outcome was particularly evident among study participants who had heart failure (HF) with preserved ejection fraction, a subtype of HF with few therapeutic options.
Amresh Raina, MD, Allegheny Health Network, Pittsburgh, PA
September 25th 2022

Dr Amresh Raina on the Importance of Treating Dominant Disease Physiology in Comorbid HF

Maggie L. Shaw
When mapping out treatment strategy, it is important to first establish dominant disease physiology in patients who have heart failure (HF) and pulmonary hypertension, explained Allegheny Health Network's Amresh Raina, MD.
Identifying Unmet Needs Surrounding Patients With Heart Failure
September 23rd 2022

Identifying Unmet Needs Surrounding Patients With Heart Failure

The panel of experts provide their final insights regarding unmet needs surrounding treatment management of heart failure.
Patient and Provider Perceptions Surrounding Affordability for HF Treatments
September 23rd 2022

Patient and Provider Perceptions Surrounding Affordability for HF Treatments

Experts share their thoughts on payer and provider perceptions surrounding affordable HF care, as well as strategies to manage care-associated costs.
Navigating Multidisciplinary HF Treatment With Multiple Comorbidities
September 23rd 2022

Navigating Multidisciplinary HF Treatment With Multiple Comorbidities

Multiple comorbidities lead to an emphasis on multidisciplinary care management when determining the most effective HF treatment strategies.
Russell Rotondo, MD, FACC, Cohere Health
September 18th 2022

Contributor: Improving Utilization Management Can Better Outcomes, Cut Costs in Cardiovascular Care

Russell Rotondo, MD, FACC
Russell Rotondo, MD, FACC, medical director of clinical strategy and innovation for cardiology at Cohere Health, discusses the myriad positive ways utilization management programs can have an impact on patient outcomes in cardiovascular care.
Amresh Raina, MD, Allegheny Health Network
September 14th 2022

Dr Amresh Raina Discusses How Heart Failure and Pulmonary Hypertension Intersect

Maggie L. Shaw
Amresh Raina, MD, is director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania.
Image of cardiac care
September 7th 2022

TAVR May Induce Early LVEF Improvement in Heart Failure

Maggie L. Shaw
This study investigated long-term mortality outcomes following transcatheter aortic valve replacement (TAVR) among patients with a left ventricular ejection fraction (LVEF) below 50% and comorbid severe aortic stenosis.
Image of a broken heart
August 29th 2022

Methamphetamine Misuse Increases Risk of Adverse Heart Health Outcomes

Maggie L. Shaw
This new study investigated risk factors for cardiovascular disease, including heart failure, among hospitalized patients with a recent history of methamphetamine use and priority patient populations to target.
What We're Reading
August 24th 2022

What We’re Reading: Premature Death Risk Factors; Pfizer Vaccine Efficacy; CVD Symptom Disparities

AJMC Staff
People who experienced childhood poverty and other adversities are at greater risk of premature death in adulthood; Pfizer’s COVID-19 vaccine is 73% effective in protecting children younger than 5 years; women experience more symptoms of heart failure and other cardiovascular diseases than men.
Image of a stethoscope in the shape of a heart
August 23rd 2022

Low-Dose Edoxaban Safe, Effective in Older Patients With AFib, High Bleeding Risk

Maggie L. Shaw
This subanalysis of data from the ELDERCARE-AF trial investigated the safety and effectiveness of a 15-mg daily dose of the factor Xa inhibitor among older patients who have atrial fibrillation (AFib).
Image of stacked quarters
August 16th 2022

Sacubitril/Valsartan Adherence Drop Linked to Lower Household Income

Maggie L. Shaw
Entresto (sacubitril/valsartan) is approved for use in adult and pediatric heart failure, and previous research shows it to be cost-effective in the long term.
Doctors consulting one another
August 10th 2022

Heart Failure Prognosis Not Improved by Risk Score Prediction

Maggie L. Shaw
The REVEAL-HF study investigated using risk scores to improve patient outcomes through targeted interventions, including treatment initiation and intensity, end-of-life care, and hospitalization and mortality risks.
New HF Guidelines Put Focus on Prevention, Bozkurt Says
August 8th 2022

New HF Guidelines Put Focus on Prevention, Bozkurt Says

Mary Caffrey
New heart failure guidelines redefine stages of the disease to emphasize prevention, said Biykem Bozkurt, MD, PhD, but more must be done by payers to identify those at high risk.
Martha Gulati, MD, MS
August 1st 2022

Gulati on Unequal CV Treatment for Women: “There Is a Bias in Our Care”

Mary Caffrey
Martha Gulati, MD, MS, kicked off the symposium “Saving the Hearts of Women Through Prevention” ahead of the 2022 Congress of the American Society for Preventive Cardiology, which took place Friday through Sunday in Louisville, Kentucky.
<123456789
...
21>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo